Instruction for use: Dexafar

Active substance: Dexamethasone

ATX Code H02AB02 Dexamethasone

Pharmacological group

Glucocorticosteroids

The nosological classification (ICD-10)

E27.4 Other and unspecified adrenocortical insufficiency

Hypocorticism, Hypoaldosteronism, Adrenal insufficiency, Insufficiency of the adrenal cortex, Insufficiency of the adrenal cortex, Secondary adrenocortical insufficiency, Secondary adrenal insufficiency, Secondary insufficiency of the adrenal cortex, Temporary decrease in the function of the adrenal cortex, Dysfunction of the adrenal cortex

G93.6 Edema of the brain

Intraoperative cerebral edema, Cerebral edema, Post-traumatic swelling of the brain, Brain edema associated with radiation therapy, Brain edema associated with head trauma, Post-traumatic cerebral edema, Edema of the brain in poisoning

J46 Status asthmaticus

Asthmatic attack, status asthmaticus, Bronchospasm in bronchial asthma

M30-M36 Systemic involvement of connective tissue

Collagenoses

R57 Shock, not elsewhere classified

Obstructive shock

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

T79.4 Traumatic shock

Hemorrhagic shock, Crush syndrome, hemorrhagic shock, postoperative shock, post-traumatic shock, traumatic shock, hemorrhagic shock and encephalopathy syndrome

T81.1 Shock during or after the procedure, not elsewhere classified

Operating shock, Postoperative shock, Operational shock

Composition and form of release

1 ampoule with 1 ml solution for injection contains dexamethasone-21-phosphate sodium 4 mg; In the package 4 pcs.

pharmachologic effect

Pharmacological action - anti-inflammatory, anti-allergic.

Indications

Adrenal insufficiency, shock, systemic connective tissue diseases, asthmatic status, allergic diseases, cerebral edema.

Contraindications

Peptic ulcer and duodenal ulcer, bacterial and viral infections, herpes, fungal infections, pre and post vaccination period, glaucoma, osteoporosis, diabetes mellitus, psychosis, cardiomyopathy, arterial hypertension, congestive heart failure, severe nephropathy.

Side effects

Itenko-Cushing's syndrome, sodium retention, edema, hypokalemia, hyperglycemia, arterial and craniocerebral hypertension, osteoporosis, peptic ulcer and duodenal ulcer, psychoses, glaucoma, cataract, growth retardation in children, adrenal insufficiency.

Dosing and Administration

In an individual dose, depending on the condition.

storage Conditions

In a dry, the dark place at a temperature below 25 ° C.

Keep out of the reach of children.

Shelf-life

3 years.

Do not use after the expiry date printed on the package.